In conclusion, our research unveiled novel findings that visfatin levels at the beginning of SARS-CoV-2-induced viral infection were significantly lower than those in the control group and, over the seven-day course, went back to the normal levels established in the control group. The gene discussed is NAMPT; the disease is viral infectious disease.